Last reviewed · How we verify

NCT05619588

Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only

Recruiting now Last updated 27 February 2025
What this trial tests

trial in Ankle Rheumatoid Arthritis in 370 participants. Currently enrolling.

Timeline
4 April 2017
Primary endpoint
31 December 2030
30 September 2031

Quick facts

Lead sponsorExactech
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment370
Start date4 April 2017
Primary completion31 December 2030
Estimated completion30 September 2031
Sites2 locations across United States

Conditions studied

Sponsor

Exactech

Who can join

21 and older, any sex, with Ankle Rheumatoid Arthritis or Arthritis of Ankle. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objectives of this study are to evaluate the performance and safety of the Vantage Total Ankle System. This study will follow subjects for a period of up to 10 years post-surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Exactech trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05619588.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing